BRCA1-associated DNA Repair Dysfunction in Patients With Early Triple Negative Breast Cancer Treated With Neoadjuvant Platinum-based Chemotherapy
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Early Triple Negative Breast Cancer
Interventions: DRUG: Doxorubicin, Paclitaxel, Cisplatin
Sponsor: Russian Academy of Medical Sciences